Konstantin Tcherepachenets

Morgan Keegan analysts Lawrence S. Keusch and Konstantin Tcherepachenets maintained their Outperform rating for shares of The Cooper Companies Inc (NYSE: COO), with a price target of $45 per share. Keusch and Tcherepachenets said that although The Cooper Companies Inc faced the risk of a slowing...

Morgan Keegan & Co. analysts Lawrence S. Keusch and Konstantin Tcherepachenets maintained their Outperform rating for shares of Baxter International Inc. (NYSE: BAX), with a blended fair value of $61. The analysts said that Baxter International Inc. was recalling as many as 20,000 of its...

Analysts Lawrence Keusch and Konstantin Tcherepachenets at Morgan Keegan have released an update on the Medical Devices industry. After an approval for the healthcare reform bill by the House of Representatives on Sunday, the path is clear now for President Barack Obama to make it into a law. As a...